Nikhil Lalwani - Aug 11, 2023 Form 4 Insider Report for ANI PHARMACEUTICALS INC (ANIP)

Role
PRESIDENT & CEO, Director
Signature
/s/ Nikhil Lalwani, by attorney-in-fact Meredith W. Cook
Stock symbol
ANIP
Transactions as of
Aug 11, 2023
Transactions value $
-$3,982,548
Form type
4
Date filed
8/15/2023, 08:39 PM
Previous filing
Mar 27, 2023
Next filing
Sep 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIP Common Stock Sale -$3.27M -56.7K -13.82% $57.75 353K Aug 11, 2023 Direct
transaction ANIP Common Stock Options Exercise $337K +11.6K +3.29% $29.00 365K Aug 15, 2023 Direct
transaction ANIP Common Stock Sale -$710K -11.6K -3.18% $61.13 353K Aug 15, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIP Stock Option (right to buy) Options Exercise -$337K -11.6K -6.47% $29.00 168K Aug 15, 2023 Common Stock 11.6K $29.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the weighted average price of sales on August 15, 2023. The shares were sold in multiple transactions at prices ranging from $60.68 to $61.87, inclusive.
F2 25% of the total options vested on each of September 8, 2021 and September 8, 2022. 25% of the total options will vest on each of September 8, 2023 and September 8, 2024.